Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar
Condition(s):Streptococcus PneumoniaeLast Updated:June 18, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Streptococcus PneumoniaeLast Updated:June 18, 2015Completed
Condition(s):Streptococcus PneumoniaLast Updated:January 5, 2023Recruiting
Condition(s):Pneumococcal PneumoniaLast Updated:March 15, 2019Completed
Condition(s):Pneumonia, Pneumococcal; Community-acquired PneumoniaLast Updated:April 8, 2022Completed
Condition(s):Pneumonia, Pneumococcal; VaccineLast Updated:March 27, 2024Not yet recruiting
Condition(s):Streptococcus PneumoniaeLast Updated:January 11, 2018Completed
Condition(s):Streptococcus PneumoniaeLast Updated:March 22, 2019Completed
Condition(s):Influenza, Human; Pneumonia, PneumococcalLast Updated:August 2, 2022Completed
Condition(s):Streptococcus PneumoniaeLast Updated:August 29, 2018Completed
Condition(s):Streptococcus PneumoniaeLast Updated:March 28, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.